What is NDC 67877-522?

67877-522 is the product NDC for Ticagrelor, Ticagrelor 60 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ticagrelor?

51 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ticagrelor NDC 67877-522 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-522Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0522Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-522-05	67877052205	500 TABLET, FILM COATED in 1 BOTTLE (67877-522-05)Marketed from Oct 28, 2025
67877-522-14	67877052214	14 TABLET, FILM COATED in 1 BOTTLE (67877-522-14)Marketed from Oct 28, 2025
67877-522-18	67877052218	180 TABLET, FILM COATED in 1 BOTTLE (67877-522-18)Marketed from Oct 28, 2025
67877-522-38	67877052238	10 BLISTER PACK in 1 CARTON (67877-522-38) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 28, 2025
67877-522-60	67877052260	60 TABLET, FILM COATED in 1 BOTTLE (67877-522-60)Marketed from Oct 28, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ticagrelor
Generic name (nonproprietary): ticagrelor
Active ingredients: Ticagrelor — 60 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210219
Marketing start: Oct 28, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)P2Y12 Receptor Antagonists (Mechanism)
Identifiers: Product ID 67877-522_0e2da4e0-7930-4f20-a63e-bd8b75cfb47dSPL ID 0e2da4e0-7930-4f20-a63e-bd8b75cfb47dSPL set ID 3225098b-3138-4aec-a866-de94c3006e8eRxCUI 1666332UNII GLH0314RVC
Pharmacologic class: P2Y12 Platelet Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877052205 followed by a unit qualifier and the quantity

Package 67877-0522-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 29, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Ticagrelor tablets are a P2Y 12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. Ticagrelor tablets also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS. ( 1.1 ) to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events. While use is not limited to this setting, the efficacy of ticagrelor tablets were established in a population with type 2 diabetes mellitus (T2DM). ( 1.2 ) to r…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-522

What is NDC 67877-522?: 67877-522 is the product NDC for Ticagrelor, Ticagrelor 60 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ticagrelor.
What is the active ingredient?: Ticagrelor.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ticagrelor?: 51 other product NDCs are listed under this name. See all Ticagrelor NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ticagrelor NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	Laurus Labs Limited	42385-994	42385-0994-0142385-0994-0542385-0994-11+4 more
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	Laurus Labs Limited	42385-993	42385-0993-0142385-0993-0542385-0993-11+4 more
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-940	72603-0940-01
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-941	72603-0941-0172603-0941-02
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-157	11788-0157-60
Ticagrelor	Ticagrelor 90 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-158	11788-0158-0111788-0158-60
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	American Health Packaging	60687-935	60687-0935-21
Ticagrelor	Ticagrelor 90 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-048	70756-0048-6070756-0048-99
Ticagrelor	Ticagrelor 60 mg/1	Tablet, Film coatedOral	Lifestar Pharma LLC	70756-047	70756-0047-60
Ticagrelor	Ticagrelor 60 mg/1	TabletOral	Oryza Pharmaceuticals, Inc.	72516-017	72516-0017-06

All 52 Ticagrelor NDCs